International Journal of Biomedicine. 2022;12(4):661-666.
Originally published December 5, 2022
Background: Prostate cancer (PC) is the most common cancer among men in Sudan. It was ranked fourth among all cancer treatment centers in Khartoum. This study aimed to assess knowledge and attitude toward PC among male medical students in their final and semifinal years at the University of Khartoum.
Methods and Results: A descriptive cross-sectional online survey was conducted at the University of Khartoum (Faculty of Medicine) on semifinal and final-year male medical students from March 2022 until May 2022. Data were collected from medical students, using a standardized, pretested, coded questionnaire that contained close-ended questions. The questionnaire was distributed online to the medical students using Google Forms. Knowledge levels were determined using 10 questions on risk factors, signs and symptoms, prevention, treatment, and complications of PC. A total of 131 participants received questionnaires, and the response rate was 100%. The results are presented in chronological order in the way they were analyzed, starting with sociodemographic characteristics of the participants, sources of information on PC, knowledge levels (low, medium, and high) of PC, and attitude levels (positive, negative) relating to the year of study. All medical students in the last 2 years have heard about PC, and medical students overwhelmingly (88.5%) believe that early detection of PC through screening improves survival. Almost all the respondents in our study indicated their willingness to go for PC screening (87.8%), and the rest of the respondents’ attitudes about the importance of PC and treatment were positive.
Conclusion: Most students have sufficient knowledge about prostate cancer, its risk factors, complications, and treatment. Medical students are an important population in studying the determinants of screening for prostate cancer.
1. Taitt HE. Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location. Am J Mens Health. 2018 Nov;12(6):1807-1823. doi: 10.1177/1557988318798279.
2. Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. 2022 Sep 5;27(17):5730. doi: 10.3390/molecules27175730.
3. Adeloye D, David RA, Aderemi AV, Iseolorunkanmi A, Oyedokun A, Iweala EE, Omoregbe N, Ayo CK. An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLoS One. 2016 Apr 13;11(4):e0153496. doi: 10.1371/journal.pone.0153496.
4. Elamin A, Ibrahim ME, Abuidris D, Mohamed KE, Mohammed SI. Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers. Cancer Med. 2015 Mar;4(3):447-56. doi: 10.1002/cam4.378.
5. Saeed IE, Weng HY, Mohamed KH, Mohammed SI. Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009-2010. Cancer Med. 2014 Aug;3(4):1075-84. doi: 10.1002/cam4.254.
6. Arafa MA, Rabah DM, Abdel-Gawad E, Ibrahim FK. Association of physicians' knowledge and behavior with prostate cancer counseling and screening in Saudi Arabia. Saudi Med J. 2010 Nov;31(11):1245-50.
7. Ali AA, Ibrahim FE. Incidence and geographical distribution of cancer in Radiation and Isotopes Center in Khartoum. Sudan Med Monit. 2014;9(3):109-112.
8. Arafa MA, Rabah DM, Wahdan IH. Awareness of general public towards cancer prostate and screening practice in Arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev. 2012;13(9):4321-6. doi: 10.7314/apjcp.2012.13.9.4321.
9. Marcella S, Delnevo CD, Coughlin SS. A national survey of medical students' beliefs and knowledge in screening for prostate cancer. J Gen Intern Med. 2007 Jan;22(1):80-5. doi: 10.1007/s11606-006-0015-1.
10. Restum S, Alloush M, Kubtan MA. Awareness of prostate cancer: A research study on Syrian private university students, Syria. J Cancer Prev Curr Res. 2021;12(1):44-46. doi: 10.15406/jcpcr.2021.12.00452
11. Jacobsen SJ, Bergstralh EJ, Guess HA, Katusic SK, Klee GG, Oesterling JE, Lieber MM. Predictive properties of serum-prostate-specific antigen testing in a community-based setting. Arch Intern Med. 1996 Nov 25;156(21):2462-8.
12. U.S. Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002 Dec 3;137(11):915-6. doi: 10.7326/0003-4819-137-11-200212030-00013.
13. Sox HC, Mulrow C. An editorial update: should benefits of radical prostatectomy affect the decision to screen for early prostate cancer? Ann Intern Med. 2005 Aug 2;143(3):232-3. doi: 10.7326/0003-4819-143-3-200508020-00011.
14. Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, Sener S, Saslow D, Eyre HJ; American Cancer Society. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2002 Jan-Feb;52(1):8-22. doi: 10.3322/canjclin.52.1.8.
Received September 22, 2022.
Accepted October 23, 2022.
©2022 International Medical Research and Development Corporation.